Modified reinforcing agent and delayed chemiluminescence liquid

By introducing a delaying agent containing catechol structure into the chemiluminescent liquid and combining a two-component enhancer, the problems of luminescence start time regulation and platform stability in the prior art are solved, and precise control of chemiluminescence is achieved and improve the accuracy of the analysis results.

CN119044155APending Publication Date: 2024-11-29GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410940826.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing enhanced chemiluminescent fluids cannot achieve regulation of the luminescence start time and a stable luminescence platform period, resulting in large test errors and coefficients of variation in immunochemiluminescence analysis and quantitative diagnosis.

Method used

Introduce compounds containing catechol structure as luminescence retardant, combine with two-component enhancer to form a new luminescence liquid, realize fine regulation of the luminescence start time of enzyme catalysts/chemiluminescence substrates, and obtain relatively stable luminescence Platform period.

Benefits of technology

Through the addition of the retardant agent, the precise regulation of the starting time of chemiluminescence and a more lasting luminescence process are achieved, which reduces the data variation coefficient and discretization in quantitative analysis and improves the accuracy of the analysis results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044155A_ABST
    Figure CN119044155A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of chemiluminescence reagents, and particularly relates to a modified reinforcing agent and delayed chemiluminescence liquid. The phenol compound containing two or more phenolic hydroxyl groups generally has a delay effect on the luminescence starting time of an enzyme catalyst / chemiluminescence substrate enhanced chemiluminescence system. The delay effect generated by the delay agent represented by protocatechuic aldehyde and protocatechuic acid is linearly related to the concentration of the delay agent, so that accurate regulation and control of the initial time of chemiluminescence become possible. By means of the regulation and control effect, precise control over the chemiluminescence imaging time sequence is achieved. In addition, the three-component modified reinforcing agent composed of the retarder / the two-component reinforcing agent not only can delay the luminescence starting time, but also can generate a more stable plateau period and a more lasting luminescence process. Due to the characteristics, the luminescent liquid has lower data variation coefficient and dispersion degree in quantitative analysis, and the accuracy of an analysis result is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of chemiluminescent reagents, and more specifically, relates to a modified enhancer and a delayed chemiluminescent liquid. Background Art

[0002] Luminol (3-amino-benzenedicarboxylic acid hydrazide) is the most widely used small molecule chemiluminescent substance, which is widely used in the field of chemiluminescent immunodiagnosis and biochemical analysis. Luminol is a classic luminescent substrate of horseradish peroxidase (HRP). Its luminescence mechanism is that HRP catalyzes peroxide (such as hydrogen peroxide H 2 O 2 Or carbamide peroxide, etc.) to oxidize luminol to produce blue chemiluminescence. However, the HRP / luminol system has the disadvantage of low luminescence efficiency. The addition of a luminescence enhancer can significantly improve the luminescence intensity and prolong the luminescence time. Commonly used luminol luminescence enhancers include phenolic compounds containing substituents at the para position, such as p-iodophenol, and a two-component enhancer composed of 4-morpholinopyridine (MORP) and sodium phenothiazine-10-propylsulfonate (SPTZ). The MORP-SPTZ two-component enhancer has been widely used to prepare luminol-based enhanced chemiluminescent liquid (ECL). Although the enhancement mechanism of chemiluminescence is still not fully understood, it is generally believed that the enhancer is a better HRP substrate than luminol. Before luminol participates in the oxidation reaction, the enhancer is first oxidized by HRP / peroxide to form a free radical intermediate of the enhancer, which promotes the oxidation and luminescence of luminol.

[0003] ECL (Enhanced Chemiluminescence) luminescent liquid containing MORP, SPTZ and luminol has been widely used in immunoblotting (WB) development due to its excellent sensitivity. At present, the luminescence characteristics of ECL luminescent liquid are: when the luminescent liquid is mixed with HRP, the luminescence intensity reaches a peak instantaneously, and then the luminescence intensity decreases rapidly over time, and there is no relatively stable plateau period for luminescence. The principle of WB development is to realize chemiluminescent imaging of protein blots by accumulating luminescent signals. It is a qualitative or semi-quantitative analysis, and the attenuation of luminescence intensity during imaging has little effect on WB imaging analysis. However, the characteristics of instantaneous peak luminescence and continuous decay require immediate development after the addition of the luminescent liquid to obtain better results, making the test process too urgent and easily causing tension in the tester.

[0004] In addition, the inherent defects of continuous luminescence attenuation and no luminescence plateau period seriously affect the application of ECL luminescent liquid in enzyme-linked immunosorbent assay (ELISA) and other quantitative diagnosis. For example, in the ELISA test based on multi-well plates, the process of adding luminescent liquid, the automatic plate entry of the equipment and the process of reading data well by well all require a certain amount of time, resulting in inconsistent HRP / luminol reaction time in each well of the same ELISA plate when reading the luminescence intensity. This time difference caused by adding samples and reading will increase the coefficient of variation of the test results because the luminescent reagent itself does not have a stable luminescence plateau period, resulting in a large test error.

[0005] In summary, developing new enhanced luminescent liquids, regulating the luminescence start time of the peroxidase / luminol system, and achieving a stable luminescence plateau period are of great significance for enhancing the accuracy of quantitative analysis and the operability of the experiment. Summary of the invention

[0006] The technical problem to be solved by the present invention is to overcome the defects and shortcomings of the existing enhanced chemiluminescent liquid that it is unable to regulate the luminescence start time and achieve a stable luminescence platform period, and to provide the use of a compound containing a catechol structure as a luminescence delay agent.

[0007] Another object of the present invention is to provide a modified reinforcing agent.

[0008] Another object of the present invention is to provide a delayed chemiluminescent liquid.

[0009] Another object of the present invention is to provide the use of the modified enhancer or the delayed chemiluminescent liquid in immunochemiluminescent analysis, information encoding technology or preparation of imaging materials.

[0010] The above-mentioned purpose of the present invention is achieved through the following technical solutions:

[0011] The present invention protects the use of a compound containing a catechol structure as a luminescence delay agent, and the luminescence system used in the luminescence delay agent includes the following components: a luminescence substrate, an enzyme catalyst, an oxidant and a luminescence enhancer;

[0012] Wherein, the luminescent substrate is a phthalic acid hydrazide luminescent molecule or a derivative thereof; the enzyme catalyst is a peroxidase; and the luminescence enhancer includes a phenothiazine compound and a pyridine compound.

[0013] Preferably, the compound containing a catechol structure is selected from one or more of the following structures:

[0014]

[0015] In view of the problem that the existing enhanced chemiluminescent liquid cannot achieve the regulation of the luminescence start time and achieve a stable luminescence platform period, the present invention creatively introduces a third component as a delay agent on the basis of a two-component enhancer (such as MORP-SPTZ), realizes the fine regulation of the luminescence start time of the enzyme catalyst / chemiluminescent substrate (such as HRP / luminol), and obtains a relatively stable luminescence platform period. The new luminescent liquid based on the delay agent and the two-component enhancer will have great application prospects in the field of immunochemiluminescence analysis.

[0016] Furthermore, the compound containing a catechol structure has different degrees of delay effect at various concentrations, and different concentrations are used according to actual needs.

[0017] Preferably, the oxidant is selected from at least one of hydrogen peroxide, urea peroxide, sodium perborate or other compounds that can generate peroxides on site. The compounds that can generate peroxides on site refer to some compounds that are not peroxides themselves but can generate peroxides on site under specific conditions.

[0018] Furthermore, the phenothiazine compound includes sodium phenothiazine-10-propyl sulfonate or its derivatives.

[0019] Furthermore, the pyridine compound includes 4-morpholinopyridine or its derivatives.

[0020] Preferably, the enzyme catalyst comprises horseradish peroxidase, potato peroxidase or soybean peroxidase.

[0021] The present invention also protects a modification enhancer, which comprises the following components: a compound containing a catechol structure, a phenothiazine compound and a pyridine compound.

[0022] Preferably, the compound containing a catechol structure is selected from one or more of the following structures:

[0023]

[0024] Furthermore, in the above-mentioned modifying and enhancing agent, the phenothiazine compound includes sodium phenothiazine-10-propyl sulfonate or its derivatives.

[0025] Furthermore, in the above-mentioned modifying and enhancing agent, the pyridine compound includes 4-morpholinopyridine or its derivatives.

[0026] Preferably, in the above-mentioned modifying and enhancing agent, the molar ratio of the phenothiazine compound to the pyridine compound is 1:(0.2-5).

[0027] The present invention protects a delayed chemiluminescent liquid, which comprises a luminescent substrate, an enzyme catalyst, an oxidant, a luminescent enhancer and a delay agent;

[0028] The luminescent substrate is a phthalic acid hydrazide luminescent molecule or a derivative thereof; the enzyme catalyst is a peroxidase; the luminescence enhancer includes a phenothiazine compound and a pyridine compound; and the delay agent is a compound containing a catechol structure.

[0029] Preferably, the compound containing a catechol structure is selected from one or more of the following structures:

[0030]

[0031] Preferably, in the above-mentioned delayed chemiluminescent liquid, the oxidant is selected from at least one of hydrogen peroxide, urea peroxide, sodium perborate or other compounds that can generate peroxide on site.

[0032] Furthermore, in the above-mentioned delayed chemiluminescent liquid, the phenothiazine compound includes sodium phenothiazine-10-propyl sulfonate or its derivatives.

[0033] Furthermore, in the above-mentioned delayed chemiluminescent liquid, the pyridine compound includes 4-morpholinopyridine or its derivatives.

[0034] Furthermore, in the above-mentioned delayed chemiluminescent liquid, the enzyme catalyst includes horseradish peroxidase, potato peroxidase or soybean peroxidase.

[0035] Preferably, in the above-mentioned delayed chemiluminescent liquid, the final concentration of the enzyme catalyst in the delayed chemiluminescent liquid is ≤50ng / mL. The enzyme catalyst has a delaying effect at various concentrations, but when the enzyme catalyst is greater than 50ng / mL, the reaction is very fast and the delay is of little significance. Theoretically, the lower the concentration, the more obvious the delay effect.

[0036] The present invention also protects the use of the modified enhancer or the delayed chemiluminescent liquid in immunochemiluminescent analysis, information encoding technology or the preparation of imaging materials.

[0037] Compared with the prior art, the present invention has the following beneficial effects: The present invention proposes that phenol compounds containing two or more phenolic hydroxyl groups generally have a delaying effect on the luminescence start time of the enzyme catalyst / chemiluminescent substrate enhanced chemiluminescent system. The delay effect produced by the delay agent represented by protocatechuic aldehyde and protocatechuic acid is linearly related to the concentration of the delay agent, which makes it possible to accurately control the start time of chemiluminescence. Utilizing this regulatory effect, the present invention achieves precise control of the timing of chemiluminescent imaging. In addition, the three-component modified enhancer composed of a delay agent / a two-component enhancer can not only delay the luminescence start time, but also produce a more stable plateau period and a more lasting luminescence process. These characteristics enable the new luminescent liquid based on the delay agent and the two-component enhancer to have a lower data coefficient of variation and discreteness in quantitative analysis, thereby improving the accuracy of the analysis results. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 Schematic diagram of the structure of phenol compounds tested in the present invention, wherein the first row of compounds contains one hydroxyl group, the second row of compounds contains two hydroxyl groups, and the third row of compounds contains three hydroxyl groups.

[0039] Figure 2 (a) is a statistical graph showing the delayed effect of compounds containing one phenolic hydroxyl group on the luminescence of HRP / luminol; (b) is a statistical graph showing the delayed effect of compounds containing two phenolic hydroxyl groups on the luminescence of HRP / luminol; (c) is a statistical graph showing the delayed effect of compounds containing three phenolic hydroxyl groups on the luminescence of HRP / luminol.

[0040] Figure 3 (a) is a statistical graph showing the delayed effect of different concentrations of protocatechuic aldehyde on the luminescence of HRP / luminol; (b) is a statistical graph showing the linear correlation between the delayed time (seconds) and the protocatechuic aldehyde concentration (0–80 μM); (c) is a statistical graph showing the delayed effect of different concentrations of protocatechuic acid on the luminescence of HRP / luminol; (d) is a statistical graph showing the linear correlation between the delayed time (seconds) and the protocatechuic acid concentration (0–90 μM).

[0041] Figure 4 The effect of adding low concentration protocatechuic acid in batches to the HRP / luminol luminescence system on luminescence (black line), and the control is a statistical diagram of the HRP / luminol reaction without adding protocatechuic acid (red line).

[0042] Figure 5 This is a statistical graph showing the effect of different concentrations of thiourea on the luminescence of HRP / luminol.

[0043] Figure 6 This is a statistical diagram of the typical signal of singlet oxygen detected by electron spin resonance spectroscopy.

[0044] Figure 7 (a) is a schematic diagram showing the order of sample addition and microplate reader data reading; (b) is a statistical graph of the coefficient of variation of luminescence intensity in the test with the addition of protocatechuic acid; (c) is a statistical graph of the coefficient of variation of luminescence intensity in the test without the addition of any delay agent.

[0045] Figure 8 The figure is a statistical diagram of the data obtained by encoding luminescence using different concentrations of a delay agent (protocatechuic acid).

[0046] Fig. 9 The figure is a statistical diagram of the data encoding the luminescence of GL-1 using different concentrations of the delay agent (protocatechuic acid). DETAILED DESCRIPTION

[0047] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0048] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.

[0049] Figure 2 a means Figure 2 In Figure (a), Figure 3 a represents Figure 3 The naming meanings of other figures are similar to Figure (a) in the figure.

[0050] Example 1 Discovery of Luminescence Delay Agent

[0051] Studies have shown that monohydroxyphenol compounds containing substituents at the para position can be used as enhancers to enhance the luminescence intensity of the HRP / luminol system, but there are no reports that phenol structures can be used as delay agents to affect the start time of HRP / luminol luminescence. The present invention tests the delay effect of phenol compounds containing one free hydroxyl group, two free hydroxyl groups, and three free hydroxyl groups on HRP / luminol luminescence.

[0052] 1. Experimental methods

[0053] The final concentrations of the substances used in the test were: luminol (100 μM), MORP (2 mM), SPTZ (1 mM), delay agent (100 μM), H 2 O 2 (2mM), HRP (5ng / mL). The specific test method is as follows.

[0054] The basic process of testing using a handheld chemiluminescence instrument is as follows: 100 μL luminol (600 μM), 100 μL MORP (12 mM), 100 μL SPTZ (6 mM), 100 μL delay agent ( Figure 1 The compound with the structure shown in the figure was mixed with 100 μL HRP (30 ng / mL) and then allowed to stand at room temperature. 2 O 2 (12 mM) was added to the above solution, shaken and mixed for 2 seconds, and then placed in a handheld luminescence recorder to read the luminescence intensity. When performing luminescence kinetics testing, the luminometer was used to read the value every 15 seconds.

[0055] 2. Experimental results

[0056] The results are as follows Figure 2 As shown, 4-hydroxybenzoic acid, vanillin and 4-iodophenol, which contain one hydroxyl group, have no delay effect on luminescence. The addition of vanillic acid delays the peak time of luminescence and has a limited delay effect. Among the molecules containing two hydroxyl groups, the molecules of resorcinol (2,4-dihydroxybenzoic acid and 3,5-dihydroxybenzoic acid) have no delay effect or a weak delay effect, and other catechol molecules (protocatechuic aldehyde, protocatechuic acid and methyl gallic acid) have obvious luminescence delay effects. Protocatechuic acid at a final concentration of 100 μM can cause a delay of 10 minutes in the start time of chemiluminescence, while protocatechuic aldehyde and methyl gallic acid produce a delay effect of about 5 minutes. The results suggest that the catechol structure is the key structure to produce the delay effect. Pyrogallol, gallic acid and methyl gallate, which contain three phenolic hydroxyl groups, all contain catechol structures, and they all produce significant delay effects. Phloroglucinol, which also contains three hydroxyl groups but does not have a diphenol structure, shows a very limited delay effect.

[0057] Importantly, these delay agents had a weak effect on the luminescence intensity of HRP / luminol at a final concentration of 100 μM, suggesting that the addition of delay agents does not affect the practical application of the system. It is not difficult to conclude from the delay time that protocatechuic acid has the best effect. Therefore, subsequent experiments were mainly conducted using protocatechuic acid, and some tests were compared with protocatechuic aldehyde.

[0058] Example 2 Fine Control of Luminescence Delay Time

[0059] According to the method of Example 1, protocatechuic aldehyde or protocatechuic acid is used as a delay agent to finely control the luminescence start time of HRP / luminol.

[0060] The results are as follows Figure 3As shown in the figure, within a certain concentration range, the luminescence delay time is linearly correlated with the concentration of the delay agent. For example, when the concentration of protocatechuic aldehyde is between 0-80 μM, there is a good linear correlation between the delay time (in seconds / s) and the concentration of protocatechuic aldehyde (correlation coefficient R 2 =0.997)( Figure 3 a~b), similarly, when the protocatechuic acid concentration was between 0-90 μM, there was an excellent linear correlation between the delay time and the protocatechuic acid concentration (R 2 =0.999)( Figure 3 c-d). Based on these linear correlations, the inventors can predict the delay effect that a given concentration of the delay agent can produce, thereby achieving fine control of the luminescence start time, which has not been achieved before the present invention.

[0061] The effect of adding low concentrations of protocatechuic acid to the HRP / luminol luminescence system in batches on luminescence (black line), and the control is the HRP / luminol reaction without the addition of protocatechuic acid (red line). 2 O 2 , 5 ng / mL HRP) were added with 100 μL of protocatechuic acid (187 μM) each time to regulate the luminescence.

[0062] By adding delay agents in batches, multiple rounds of ON-OFF-ON regulation of luminescence can be achieved, such as Figure 4 As shown in the figure, when the HRP / luminol luminescence reaches its peak, the addition of the delay agent protocatechuic acid can quickly inhibit the luminescence, and the luminescence is quenched for a period of time and then restored. At this time, adding protocatechuic acid again can realize the quenching-recovery cycle. Through three rounds of control, the overall luminescence process of the system can be sustained for a longer time.

[0063] Example 3 Preliminary Study on Delay Mechanism

[0064] According to the method of Example 1, the delay agent was replaced with thiourea of ​​different concentrations, and the luminescence test solution contained 100 μM luminol, 2 mM MORP, 1 mM SPTZ, 2 mM H 2 O 2 , 5 ng / mL HRP and different concentrations of thiourea (the final concentration in the system was 100 μM, 1 mM, 2 mM or 3 mM).

[0065] The results are as follows Figure 5 As shown, thiourea at high concentrations (mmol / L level) had a severe quenching effect on luminescence and had no luminescence delay effect. When the thiourea concentration was reduced to 100 μM, it did not show any delay effect and had no obvious effect on the luminescence of HRP / luminol.

[0066] From the above, it can be seen that the HRP / luminol delayed luminescence system containing catechol compounds provided by the present invention and the above-mentioned Mn 2+ The HRP / MORP / SPTZ / HRP system is essentially different from the luminol system. It may involve different free radical oxidation processes. For this reason, the present invention adds the free radical scavenging agent 2,2,6,6-tetramethylpiperidinyl oxide (TEMPO) to the HRP / MORP / SPTZ / HRP system. 2 O 2 The reaction system was prepared and its electron spin resonance (ESR) spectrum was obtained. Figure 6 As shown in Figure 2, the ESR signal presents three peaks with an abundance of 1:1:1, indicating that the enzymatic reaction system mainly produces singlet oxygen rather than Mn 2+ / H 2 O 2 Superoxide anions and hydroxyl radicals observed in the system.

[0067] Singlet oxygen is one of the active oxygen species that can oxidize luminol to produce chemiluminescence. Therefore, it is preliminarily speculated that protocatechuic acid, protocatechuic aldehyde and other catechol compounds as delay agents may delay the oxidation of luminol by reacting with singlet oxygen, thus achieving the chemiluminescence delay effect. However, the specific mechanism involves a complex free radical reaction process, which is difficult to fully reveal.

[0068] Example 4 New three-component enhancer reduces the coefficient of variation of test results

[0069] (a) Schematic diagram showing the order of sample addition and microplate reader data reading. Sample addition and reading are performed column by column from left to right; (b) In the test with protocatechuic acid, the average luminescence intensity of three test wells in different columns and the coefficient of variation of the luminescence intensity of all 27 wells.

[0070] Add delay agent group: In the first to ninth columns of the 96-well plate (3 wells in each column), add 30 μL of luminol (600 μM), 90 μL of three-component enhancer (containing 200 μM protocatechuic acid, 4 mM MORP, 2 mM SPTZ, and 30 μL HRP (30 ng / mL) to each well. After mixing the above reagents, add 30 μL HRP from left to right. 2 O 2 The solution (12 mM) was reacted for 15 minutes and then the luminescence intensity was read.

[0071] No delay agent addition group: In the first to ninth columns of the 96-well plate (3 wells in each column), 30 μL luminol (600 μM), 60 μL two-component enhancer (containing MORP 6 mM, SPTZ 3 mM), 30 μL HRP (30 ng / mL), and 30 μL Trisbuffer (pH 8.5) were added to each well. After mixing the above reagents, 30 μL HRP was added from left to right. 2 O 2 Solution (12mM), read the luminescence intensity immediately. Use a multifunctional microplate reader to read the chemiluminescence, and read the plate order from left to right, read the first three wells from top to bottom, then read the second three wells from top to bottom, and so on.

[0072] The results are as follows Figure 7 As shown in FIG. 1 , the use of a delay agent combined with the classic MORP / SPTZ to form a three-component enhancer can not only achieve precise control of the luminescence start time, but also achieve a more stable luminescence plateau. The inventors speculate that this luminescence characteristic can reduce the coefficient of variation of the HRP quantitative analysis results. Therefore, the present invention is carried out as follows Figure 7 In the luminescence test shown in a, the test conditions of the 27 sample wells (such as HRP concentration and the concentration of other components) remain consistent, and the only variable is the time difference caused by the sample addition and data reading process. Figure 7 b and Figure 7 c shows that in the system with the addition of the three-component enhancer, the average luminescence intensity from the first column to the ninth column tends to change smoothly ( Figure 7 b), while the luminescence intensity in the corresponding two-component enhancer system shows an increasing trend ( Figure 7 c). This is mainly due to a certain time difference caused by the sample addition and plate reading process from left to right, so that when reading the luminescence intensity, the time of the luminescence reaction from the ninth column to the first column increases successively, and the degree of luminescence decay increases successively. The coefficient of variation CV of the luminescence intensity of all 27 wells of the luminescence system containing the three-component enhancer (protocatechuic acid / MORP / SPTZ) is 3.4%, while the coefficient of variation of the classic two-component enhancer system (MORP / SPTZ) is 11.3%, which is 3.3 times that of the former. The higher the coefficient of variation, the greater the degree of discreteness of the data and the lower the consistency. Therefore, the test results show that the new three-component luminescence enhancer provided by the present invention can indeed reduce the coefficient of variation of the quantitative results of the HRP / luminol detection system. This characteristic will significantly increase the accuracy of quantitative analysis and has important application prospects.

[0073] Example 5: A novel delayed luminescent liquid achieves fine control of chemiluminescent imaging

[0074] Luminol was used as the luminescent substrate: different concentrations of delay agent (protocatechuic acid) were used to encode the luminol luminescence. The final concentrations of each component in each well were luminol 100 μM, MORP 2 mM, SPTZ 1 mM, HRP 40 ng / mL, H 2 O 2 2mM, the concentrations of protocatechuic acid in the first well to the eighth well are 0, 20, 30, 40, 50, 60, 70, 80μM. The test process is as follows: different concentrations of protocatechuic acid are mixed with luminol, MORP, SPTZ, and HRP in a 96-well plate, and then H 2 O 2 For chemiluminescent imaging, a camera was used to take pictures continuously every 2 seconds.

[0075] Using luminol derivatives as luminescent substrates (GL-1): different concentrations of delay agents (protocatechuic acid) were used to encode the luminescence of GL-1. The final concentrations of each component in each well were GL-1 100μM, MORP 2mM, SPTZ 1mM, HRP 40ng / mL, H 2 O 2 2mM, the concentrations of protocatechuic acid in the first well to the eighth well are 0, 20, 30, 40, 50, 60, 70, 80μM. The test process is as follows: different concentrations of protocatechuic acid are mixed with luminol, MORP, SPTZ, and HRP in a 96-well plate, and then H 2 O 2 For chemiluminescent imaging, a camera was used to take pictures continuously every 2 seconds.

[0076] The results are as follows Figures 8-9 As shown, by adjusting the concentration of the delay agent, the start time of luminescence can be finely controlled. Based on this, the present invention can achieve precise control of the timing of HRP / luminol chemiluminescence imaging. Figure 8 As shown, the present invention adds different concentrations of protocatechuic acid to the HRP / luminol luminescent solution. From the first well to the eighth well, the concentration of protocatechuic acid increases successively. 2 O 2 Imaging was performed immediately after that. The results showed that by controlling the start time of luminescence, the first to eighth wells could be lit up in sequence (generating chemiluminescence). At the same time, this enhancer system is also applicable to other luminol derivatives, such as the green luminol derivative GL-1 (Fuqian Chen) reported by the inventors earlier. # ,Xiaotong Xia #, Dong Yea, Ting Li, Xinxin Huang, Chun Cai, Chenchen Zhu, Chaozhan Lin, Tao Deng*, Fang Liu* A Green-emitting Luminol Analogue as the Next Generation Chemiluminescent Substratein Biochemical Analysis. Analytical Chemistry, 2023, 95, 5773–5779). like Fig. 9 As shown in the figure, by adding different concentrations of delay agents to the HRP / GL-1 luminescent system, the luminescence start time can be precisely controlled. This excellent luminescence control makes it possible to achieve fine chemiluminescent coding using the HRP / luminol system.

[0077] In summary, the present invention proposes that phenol compounds containing two or more phenolic hydroxyl groups generally have a delaying effect on the luminescence start time of the HRP / luminol enhanced chemiluminescence system. The delay effect produced by the delay agent represented by protocatechuic aldehyde and protocatechuic acid is linearly related to the concentration of the delay agent, which makes it possible to accurately regulate the start time of chemiluminescence. Utilizing this regulatory effect, the present invention achieves precise control of the timing of chemiluminescence imaging. In addition, the three-component enhancer composed of delay agent / MORP / SPTZ can not only delay the luminescence start time, but also produce a more stable plateau and a more lasting luminescence process. These characteristics enable these luminescent liquids to have lower data variation coefficients and discreteness in quantitative analysis, thereby improving the accuracy of the analysis results. The relevant delay agents are all common compounds and are easily commercially available. Therefore, the new enhanced luminescent liquid is easier to achieve large-scale preparation.

[0078] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. Application of compounds containing catechol structure as luminescence delay agents, It is characterized in that The luminescence system used in the luminescence delay agent includes the following components: a luminescence substrate, an enzyme catalyst, an oxidant and a luminescence enhancer; Wherein, the luminescent substrate is a phthalic acid hydrazide luminescent molecule or a derivative thereof; the enzyme catalyst is a peroxidase; and the luminescence enhancer includes a phenothiazine compound and a pyridine compound.

2. The use according to claim 1, It is characterized in that The compound containing a catechol structure is selected from one or more of the following structures:

3. The use according to claim 1, It is characterized in that The oxidant is selected from at least one of hydrogen peroxide, urea peroxide, sodium perborate or other compounds that can generate peroxide on site.

4. The use according to claim 1, It is characterized in that The phenothiazine compound includes sodium phenothiazine-10-propylsulfonate or its derivatives.

5. The use according to claim 1, It is characterized in that The pyridine compound includes 4-morpholinopyridine or its derivatives.

6. A modifying and reinforcing agent, It is characterized in that The modifying and reinforcing agent comprises the following components: a compound containing a catechol structure, a phenothiazine compound and a pyridine compound.

7. The modifying and reinforcing agent according to claim 6, It is characterized in that The compound containing a catechol structure is selected from one or more of the following structures:

8. A delayed chemiluminescent liquid, It is characterized in that The delayed chemiluminescent liquid comprises a luminescent substrate, an enzyme catalyst, an oxidant, a luminescent enhancer and a delay agent; The luminescent substrate is a phthalic acid hydrazide luminescent molecule or a derivative thereof; the enzyme catalyst is a peroxidase; the luminescence enhancer includes a phenothiazine compound and a pyridine compound; and the delay agent is a compound containing a catechol structure.

9. The delayed chemiluminescent liquid according to claim 8, It is characterized in that The compound containing a catechol structure is selected from one or more of the following structures:

10. Use of the modified enhancer according to claim 6 or 7 or the delayed chemiluminescent liquid according to claim 8 or 9 in immunochemiluminescent analysis, information encoding technology or preparation of imaging materials.

Citation Information

Cited By

  • Application of light-emitting retarder in aspect of improving development quality of solid-phase membrane immunodetection

    CN121476578A